Neurology
1 drug is in development for Frontotemporal Dementia.
- Companies
- 1
- Clinical trials
- 9
Prepared research question
Which programs lead the Frontotemporal Dementia pipeline—and what evidence could change the picture?
Traceable citations · Unknowns marked
Drug Pipeline by Phase
| Drug | Company |
|---|---|
| pbft02 | Passage BIO, Inc. (PASG) |
About this indication
Frontotemporal Dementia context
Also known as: Complices, Disinhibition-Dementia-Parkinsonism-Amyotrophy, Complices, Disinhibition-Dementia-Parkinsonism-Amytrophy, DDPAC, Dementia, Frontotemporal Lobe (FLDEM), Dementia, Frontotemporal, with Parkinsonism, Dementia, GRN-Related Frontotemporal, Dementia, Hereditary Dysphasic Disinhibition, Dementia, Ubiquitin-Positive Frontotemporal, Dementias, Frontotemporal, Dementias, Frontotemporal Lobe (FLDEM), Dementias, GRN-Related Frontotemporal, Dementias, Ubiquitin-Positive Frontotemporal, Disease, Familial Pick's, Disease, Wilhelmsen-Lynch, Diseases, Familial Pick's, Diseases, Wilhelmsen-Lynch, Disinhibition Dementia Parkinsonism Amyotrophy Complex, Disinhibition Dementia Parkinsonism Amytrophy Complex, FTD-GRN, FTD-PGRN, FTDP-17, FTLD with TDP 43 Pathology, FTLD-17 GRN, FTLD-TDP, Familial Pick Disease, Frontotemporal Dementia with Parkinsonism, Frontotemporal Dementia with Parkinsonism 17, Frontotemporal Lobar Degeneration With Ubiquitin Positive Inclusions, HDDD1, HDDD2, Multiple System Tauopathy with Presenile Dementia
Frequently asked questions
How many drugs are in development for Frontotemporal Dementia?
BioSniper tracks 1 drug in development for Frontotemporal Dementia across 1 company.
How many clinical trials target Frontotemporal Dementia?
There are 9 clinical trials targeting Frontotemporal Dementia tracked by BioSniper.